Kriya Therapeutics logo

Kriya Therapeutics Funding & Investors

Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.

kriyatherapeutics.com

Total Amount Raised: $600,499,968

Kriya Therapeutics Funding Rounds

  • Series C

    $150,000,000

    Series C Investors

    Patient Square Capital
  • Series C

    $270,000,000

    Series C Investors

    Bluebird Ventures
    Lightswitch Capital
    Alumni Ventures
    QVT Financial
    JDRF T1D Fund
    Patient Square Capital
    Foresite Capital
    Transhuman Capital
    Narya Capital
    Dexcel Pharma
    CAM Capital
  • Series B

    $100,000,000

    Series B Investors

    Woodline Partners
    Alumni Ventures
    QVT Financial
    JDRF T1D Fund
    Amplo Management
    Patient Square Capital
    Transhuman Capital
    Dexcel Pharma
    Bluebird Ventures
    Hongkou
    Foresite Capital
    Narya Capital
    CAM Capital
  • Series A

    $80,500,000

    Series A Investors

    Bluebird Ventures
    QVT Financial
    JDRF T1D Fund
    Sahsen Ventures
    Amplo Management
    Foresite Capital
    Narya Capital
    Transhuman Capital
    Paul Manning
    Dexcel Pharma
Funding info provided by Diffbot.